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Pinched cone conformationAbstract In this study, six iminecalix[4]arenes were synthesized and the crystal structures of two of
the iminecalix[4]arenes were also determined. Iminecalix[4]arene adopts a strongly pinched cone
conformation with two upper rim substituents pointing toward and the other two pointing away
from the aromatic cavity. This uncommon conformation is stabilized by an intramolecular p. . .p
interaction between the phenyl rings from the upper rim substituents pointing inwards the cone.
In addition, phenyl rings from the substituent groups are not coplanar with respect to the calixarene
phenyl rings holding them. The compounds, as well as their respective monomeric units, were eval-
uated for their antifungal activities against Candida strains. All the synthesized iminecalix[4]arenes
were found to cause higher inhibition of all tested Candida strains than their respective monomers.
The ratio between the minimal inhibitory concentration (MIC) of a monomer and the correspond-
ing iminecalix[4]arene ranged from 2.05 to 36.50. Furthermore, the iminecalix[4]arene bearing nitro-
furan group exhibited low MIC values comparable to that of fluconazole. Thus, this compound was
twice more active than fluconazole against Candida krusei.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In the last few decades, calixarenes and their functionalized derivatives
have attracted increasing attention due to their technological and bio-
logical applications (Consoli et al., 2006, 2011; Motornaya et al., 2006;
Mourer et al., 2010, 2012; Patel et al., 2012; Ukhatskaya et al., 2013;
Pelizzaro-Rocha et al., 2013), particularly as platforms for the develop-
ment of new drugs (de Fa´tima et al., 2009; Vareja˜o et al., 2013;
Lappchen et al., 2015; Tauran et al., 2015; Giuliani et al., 2015). TheArabian
2 C.M. da Silva et al.highly organized structures of the calixarenes could give rise to inter-
esting synergistic effects that are not observed in their respective mono-
meric units. In this sense, studies conducted in 2007 by Grare and
coworkers indicate that a p-guanidinoethylcalix[4]arene shows broad
spectrum antibacterial activity, while no antibacterial activity was
observed with the corresponding monomer guanidinoethylphenol
(Grare et al., 2007). Two years later, the same group reported that
other three p-guanidinoethylcalix[4]arenes also possess, in general, bet-
ter antibacterial activities than their corresponding monomers (Mourer
et al., 2009). Characteristics such as easy-to-perform in multi-gram
scale synthesis from low cost precursors, chemical and thermal stabil-
ity, and easiness of functionalization make calixarenes versatile plat-
forms for the development of a wide range of compounds with
applications in medicinal chemistry (Krˇenek et al., 2007; Deshayes
and Gref, 2014; Guo and Liu, 2014; Kamboh et al., 2014; Du et al.,
2015).
Fungi have remained neglected pathogens in terms of drug discov-
ery (Sundriyal et al., 2006; Choi et al., 2014) despite their highlighted
clinical relevance (Andriole et al., 1999; Ascioglu et al., 2002; Nucci
et al., 2005; Franco-Paredes et al., 2015). The Candida species are cer-
tainly the most important opportunistic fungal pathogens for humans
(Pfaller et al., 2006; Pfaller and Diekema, 2007; Whibley and Gaffen,
2015). Candidiasis may range from non-life threatening mucocuta-
neous illnesses to invasive processes (Pappas et al., 2004; Sparber
and LeibundGut-Landmann, 2015). Both mucosal and deep tissue
infections are mainly caused by C. albicans (Pappas et al., 2004). Can-
dida species other than albicans have been assumed to be the pathogens
of nosocomial infections in immunocompromised patients (Walsh
et al., 1995; Girmenia et al., 1996; Whibley and Gaffen, 2015). Con-
cerning the currently available antifungal drugs, most active com-
pounds exhibit drawbacks, such as fungi resistance, toxicity, limited
efficacy, and high cost (Sundriyal et al., 2006; Rizi et al., 2015). This
scenario clearly indicates that research on new antifungal agents is
required.
Aldimines are known to exhibit remarkable biological properties
(Abdallah et al., 2010; da Silva et al., 2011a; Sztanke et al., 2013;
Matar et al., 2015; Amnerkar et al., 2015; Hisaindee et al., 2015).
Recently, our research group demonstrated that aldimines show inter-
esting inhibitory activity against a variety of pathogenic fungi, includ-
ing Candida, Aspergillus, and Cryptococcus species (da Silva et al.,
2011b; Magalha˜es et al., 2013; Gasparto et al., 2015). Calixarenes have
also demonstrated antifungal profiles (Paquet et al., 2006; Patel et al.,
2012; de Oliveira et al., 2012). In this context, the synthesis of hybridScheme 1 Synthesis of iminecalix[4]arenes 6–11. (i) Diphenyl ether, N
n-BuBr, DMF, 80 C, 60%; (iv) HOAc/HNO3, r.t., 54%; (v) N2H4
irradiation, 52–90%.
Please cite this article in press as: da Silva, C.M. et al., Iminecalix[4]arenes: Microwav
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.06.013calixarene–aldimines presents a promising strategy for obtaining new
compounds with enhanced antifungal activity. Calixarene-based
aldimines have been successfully synthesized previously as precursors
of anion receptor in water (Klimentova´ and Vojtı´sˇek, 2007). We here
report the microwave-assisted synthesis of six iminecalix[4]arenes
(compounds 6–11; Scheme 1) and their respective monomeric units
(compounds 14–19; Scheme 2). Crystal structures of two of the synthe-
sized compounds were determined. The antifungal activities against six




All chemicals were obtained from commercially available
sources and used without further purification. Melting points
(uncorrected) were determined on Mettler FP 80 HT appara-
tus. Infrared spectra were recorded on a Perkin Elmer Spec-
trum One spectrophotometer (ATR). 1H and 13C NMR
spectra were recorded on a Bruker AVANCE DPX-200 spec-
trometer or a VARIAN MERCURY-300 spectrometer in
CDCl3. High-resolution mass spectra were recorded on a Shi-
madzu LCMS-IT-TOF instrument. Compounds 5 and 13
(Schemes 1 and 2) were synthesized according to procedures
reported in the literature (Li et al., 2009, 2011).
Well-shaped single crystals of compounds 7 and 10
(Schemes 1 and 2) with dimensions of
0.32  0.21  0.05 mm3 and 0.25  0.012  0.05 mm3 were
exposed to the X-ray beam (Mo Ka or Cu Ka radiation from
IlS microsources with multilayer optics) at room temperature
using a Bruker-AXS Kappa Duo diffractometer equipped with
an APEX II CCD detector. The diffraction frames were
recorded by u and x scans using APEX2 (Bruker, 2012),
and this software package was also employed for treatment
of the raw dataset. The structures were solved using direct
methods of phase retrieval with SHELXS-97 (Sheldrick,
2008). Identification of C, O, and N atoms was done directly
from the Fourier synthesis maps, which were then refined withaOH, 260 C, 56%; (ii) AlCl3, phenol, toluene, r.t., 80%; (iii) NaH,
H2O, Pd/C, EtOH, 80 C, 99%; (vi) ArCHO, EtOH, microwave
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Scheme 2 Synthesis of the monomer units 14–19. (i) K2CO3, n-BuBr, MeCN, 80 C, 94%; (ii) N2H4H2O, Pd/C, EtOH, 80 C, 99%; (iii)
ArCHO, EtOH, microwave irradiation, 69–88%.
Synthesis, crystal structures, and anticandidal activity of iminecalix[4]arenes 3anisotropic atomic displacement parameters (ADPs). All
refinements were performed using the full-matrix least squares
method on F2 using SHELXL-97 (Sheldrick, 2008). Hydrogen
atoms were stereochemically positioned with fixed individual
isotropic ADPs based on the equivalent isotropic ADP of
the parent non-hydrogen atom [Uiso(H) = 1.2 Ueq or 1.5
Ueq (only in the case of methyl carbons and hydroxyl oxy-
gens)] using a riding model with fixed CAH bond lengths of
either 0.93 A˚ (Csp2), 0.97 A˚ (Csp3 in methylene groups), or
0.96 A˚ (Csp3 in methyl groups) and a OAH bond length of
0.82 A˚. The MERCURY (Macrae et al., 2008) and ORTEP-
3 (Farrugia, 2012) programs accessed through the WinGX
(Farrugia, 2012) software package were used to prepare struc-
ture illustrations. CCDC reference numbers 1439308 and
1439309 contain the crystal data for compounds 7 and 10,
respectively.
Additionally, a positional disorder in the upper rim sub-
stituent at calixarene phenyl rings 2 and 4 was found in the
case of compound 7 and was refined using the classical split-
atom approach. Two sets of atomic sites were found for each
substituent. Their major occupancies were constrained to
55% and 60% for the substituents at phenyl rings 2 and 4,
respectively. The minor occupancy factors were constrained
to 45% and 40%, and their labels followed those from major
ones but ended with apostrophe.
Crystal data for compound 7. C72H76N4O8, MW= 1125.37,
monoclinic, a= 12.405(5) A˚, b= 30.137(12) A˚, c= 17.782
(7) A˚, b= 101.502(9), V= 6514(4) A˚3, T= 297(2) K, space
group P21/c, Z= 4, Dc= 1.148 g cm
3, l (Mo Ka)
= 0.075 mm1, h-range for data collection = 1.35–25.49,
14 6 h 6 15, 36 6 k 6 33, 9 6 l 6 21, 53,392 reflections
collected, 11,865 unique (Rint = 0.0706), 4797 with I> 2r(I),
completeness to hmax = 97.9%, F000 = 2400, 918 parameters
refined, S= 1.145, R1(I> 2r(I)) = 0.1262, wR2(all data)
= 0.3987, largest diff. peak/hole = 0.714/0.463 e A˚3.
Crystal data for compound 10. C76H76N4O12,
MW= 1237.41, monoclinic, a= 13.713(4) A˚, b= 28.956(9)
A˚, c= 17.592(6) A˚, b= 103.184(18), V= 6801(4) A˚3,
T= 297(2) K, space group P21/c, Z= 4, Dc= 1.209 g cm
3,
l (Mo Ka) = 0.082 mm1, h-range for data collection = 1.68–
25.45, 16 6 h 6 16, 34 6 k 6 34, 21 6 l 6 19, 70,533
reflections collected, 12,361 unique (Rint = 0.0685), 6191 with
I> 2r(I), completeness to hmax = 98.2%, F000 = 2624, 833
parameters refined, S= 1.084, R1(I> 2r(I)) = 0.0861,
wR2(all data) = 0.2574, largest diff. peak/hole =
0.360/0.321 e A˚3.
Unit cell data for compound 11. monoclinic, a= 14.79(3) A˚,
b= 33.55(9) A˚, c= 13.41(3) A˚, b= 100.68(8), V= 6539Please cite this article in press as: da Silva, C.M. et al., Iminecalix[4]arenes: Microwav
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.06.013(27) A˚3, T= 297(2) K, h-range for data collection (Cu Ka)
= 7.22–42.04, 10 6 h 6 9, 24 6 k 6 27, 7 6 l 6 11, 3083
reflections collected, 2684 unique (Rint = 0.0479), 1241 with
I> 2r(I).
2.1.2. General procedure for synthesis of iminecalix[4]arenes 6–
11
Compound 5 (0.15 mmol) and respective aldehydes
(0.66 mmol, 1.1 equivalents for amino group) were solubilized
in ethanol (20 mL). The mixtures were irradiated in a Discover
CEM reactor for 20 min at reflux temperature. After
the reaction was complete, the products were isolated by
filtration.
Yield: 52%. Yellow solid. Mp: 136.3–137.8 C. IR (ATR,
cm1) v: 2957, 2929, 2869, 1624, 1576, 1457, 1378, 1310,
1237, 1205, 1117, 1069, 1023, 999, 967, 884, 849, 753. 1H
NMR (300 MHz, CDCl3): d 1.03 (t, 12H, J8,7 = 7.4 Hz, H8),
1.49 (sex, 8H, J7,6 = J7,8 = 7.4 Hz, H7), 1.97 (quin, 8H,
J6,5 = J6,7 = 7.4 Hz, H6), 3.25 (d, 4H, Jb,a = 13.0 Hz, Hb),
3.96 (t, 8H, J5,6 = 7.4 Hz, H5), 4.52 (d, 4H, Ja,b = 13.0 Hz,
Ha), 6.79 (s, 8H, H3), 7.20–7.33 (m, 12H, H12, H13), 7.66
(dd, 8H, J11,12 = 8.4 Hz, J11,13 = 1.5 Hz, H11), 8.14 (s, 4H,
H9).
13C NMR (75 MHz, CDCl3): d 14.4 (C8), 19.6 (C7),
31.5, 32.5 (C6, CH2), 75.4 (C5), 121.1 (C3), 128.6, 128.8 (C11,
C12), 130.8 (C13), 135.5 (C2), 136.5 (C10), 146.5 (C4), 155.4
(C1), 158.9 (C9). HRMS (ESI, IT-TOF) calculated for
C72H77N4O4
+: 1061.5939; found: 1061.6016.e-assisted synthesis, X-ray crystal structures, and anticandidal activity. Arabian
4 C.M. da Silva et al.Yield: 85%. Yellow solid. Mp: 285.5–286.8 C. IR (ATR,
cm1) v: 2957, 2869, 1614, 1573, 1462, 1276, 1207, 1150,
1117, 1065, 1003, 958, 868, 794. 1H NMR (300 MHz, CDCl3):
d 1.05 (t, 12H, J8,7 = 7.4 Hz, H8), 1.50 (sex, 8H,
J7,6 = J7,8 = 7.4 Hz, H7), 1.96 (quin, 8H,
J6,5 = J6,7 = 7.4 Hz, H6), 3.28 (d, 4H, Jb,a = 13.3 Hz, Hb),
3.98 (t, 8H, J5,6 = 7.4 Hz, H5), 4.54 (d, 4H, Ja,b = 13.3 Hz,
Ha), 6.71–6.79 (m, 16H, H3, H12, H14), 7.14–7.24 (m, 8H,
H13, H15), 8.28 (s, 4H, H9), 13.25 (s, 4H, OH).
13C NMR
(75 MHz, CDCl3): d 14.3 (C8), 19.6 (C7), 31.6, 32.4 (C6,
CH2), 75.5 (C5), 117.0, 118.8 (C12, C14), 119.4 (C10), 121.1
(C3), 132.1, 132.6 (C13, C15), 135.9 (C2), 142.9 (C4), 156.1
(C11), 161.0 (C1, C9). HRMS (ESI, IT-TOF) calculated for
C72H77N4O8
+: 1125.5736; found: 1125.5809.
Yield: 90%. Yellow solid. Mp: 243.4–245.9 C. IR (ATR,
1cm ) v: 2930, 1597, 1519, 1456, 1291, 1207, 1106, 1065, 999,
975, 888, 850, 838, 747, 688. 1H NMR (300 MHz, CDCl3): d
1.04 (t, 12H, J8,7 = 7.4 Hz, H8), 1.50 (sex, 8H, J7,6 =
J7,8 = 7.4 Hz, H7), 1.96 (quin, 8H, J6,5 = J6,7 = 7.4 Hz, H6),
3.29 (d, 4H, Jb,a = 13.4 Hz, Hb), 3.99 (t, 8H, J5,6 = 7.4 Hz,
H5), 4.54 (d, 4H, Ja,b = 13.4 Hz, Ha), 6.77 (s, 8H, H3), 7.80
(d, 2H, J11,12 = 8.6 Hz, H11) 8.09 (d, 2H, J12,11 = 8.6 Hz,
H12), 8.23 (s, 1H, H9).
13C NMR (75 MHz, CDCl3): d 14.3Please cite this article in press as: da Silva, C.M. et al., Iminecalix[4]arenes: Microwav
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.06.013(C8), 19.6 (C7), 31.5, 32.5 (CH2, C6), 75.5 (C5), 121.5 (C3),
123.9 (C12), 129.1 (C11), 135.9 (C2), 141.8, 145.2 (C4, C10),
148.9 (C13), 155.5 (C9), 156.7 (C1). HRMS (ESI, IT-TOF) cal-
culated for C72H73N8O12
+: 1241.5342; found: 1241.5656.
Yield: 73%. Yellow solid. Mp: 272.5–273.6 C. IR (ATR,
cm1) v: 2956, 2870, 1625, 1601, 1587, 1507, 1457, 1378,
1293, 1151, 1067, 1025, 1000, 974, 956, 887, 858, 834. 1H
NMR (300 MHz, CDCl3): d 1.03 (t, 12H, J8,7 = 7.4 Hz, H8),
1.48 (sex, 8H, J7,6 = J7,8 = 7.4 Hz, H7), 1.96 (quin, 8H,
J6,5 = J6,7 = 7.4 Hz, H6), 3.24 (d, 4H, Jb,a = 13.2 Hz, Hb),
3.95 (t, 8H, J5,6 = 7.4 Hz, H5), 4.51 (d, 4H, Ja,b = 13.2 Hz,
Ha), 6.67 (s, 8H, H3), 6.95 (t, 8H, J12,11 = J12,F = 8.6 Hz,
H12), 7.63 (dd, 8H, J11,12 = 8.6 Hz, J11,F = 5.5 Hz, H11),
8.06 (s, 4H, H9).
13C NMR (75 MHz, CDCl3): d 14.4 (C8),
19.6 (C7), 31.5, 32.5 (CH2, C6), 75.4 (C5), 115.7 (d, J12,
F = 21.9 Hz, C12), 121.1 (C3), 130.6 (d, J11,F = 8.6 Hz, C11),
132.8 (d, J10,F = 2.9 Hz, C10), 135.6 (C2), 146.2 (C4), 155.6
(C1), 157.3 (C9), 164.3 (d, J13,F = 251.6 Hz, C13). HRMS
(ESI, IT-TOF) calculated for C72H73F4N4O4
+: 1133.5562;
found: 1133.5650.e-assisted synthesis, X-ray crystal structures, and anticandidal activity. Arabian
calix[4]arenes 5Yield: 78%. Brown solid. Mp: 195.0–196.2 C. IR (ATR,
1cm ) v: 2868, 1622, 1601, 1584, 1504, 1488, 1445, 1379,
1347, 1208, 1098, 1064, 1035, 1002, 933, 876, 801. 1H NMR
(300 MHz, CDCl3): d 1.02 (t, 12H, J8,7 = 7.5 Hz, H8), 1.48
(sex, 8H, J7,6 = J7,8 = 7.5 Hz, H7), 1.95 (quin, 8H,
J6,5 = J6,7 = 7.5 Hz, H6), 3.22 (d, 4H, Jb,a = 13.3 Hz, Hb),
3.93 (t, 8H, J5,6 = 7.5 Hz, H5), 4.48 (d, 4H, Ja,b = 13.3 Hz,
Ha), 5.97 (s, 8H, OCH2O), 6.64 (s, 8H, H3), 6.69 (d, 4H,
J14,15 = 8.0 Hz, H14), 7.04 (dd, 4H, J15,14 = 8.0 Hz,
J15,11 = 1.3 Hz, H15), 7.23 (d, 4H, J11,15 = 1.3 Hz, H11), 7.92
(s, 4H, H9).
13C NMR (75 MHz, CDCl3): d 14.3 (C8), 19.6
(C7), 31.5, 32.5 (C6, CH2), 75.3 (C5), 101.6 (OCH2O), 106.9,
108.0 (C11, C14), 121.0 (C3), 125.5 (C15), 131.6 (C10), 135.6
(C2), 146.3, 148.1, 149.9 (C4, C12, C13), 155.2 (C1), 157.9
(C9). HRMS (ESI, IT-TOF) calculated for C76H77N4O12
+:
1237.5533; found: 1237.5636.
Yield: 69%. Brown solid. Mp: 181.2 C (decomposition).
IR (ATR, cm1) v: 2957, 2931, 2870, 1571, 1523, 1487, 1458,
1394, 1282, 1294, 1211, 1117, 1064, 1017, 962, 880, 808, 736.
1H NMR (300 MHz, CDCl3): d 1.03 (t, 12H, J8,7 = 7.4 Hz,
H8), 1.48 (sex, 8H, J7,6 = J7,8 = 7.4 Hz, H7), 1.94 (quin, 8H,
J6,5 = J6,7 = 7.4 Hz, H6), 3.25 (d, 4H, Jb,a = 13.4 Hz, Hb),
3.97 (t, 8H, J5,6 = 7.4 Hz, H5), 4.50 (d, 4H, Ja,b = 13.4 Hz,
Ha), 6.74 (s, 8H, H3), 7.01 (d, 4H, J11,12 = 3.8 Hz, H11), 7.28
(d, 4H, J12,11 = 3.8 Hz, H12), 8.10 (s, 4H, H9).
13C NMR
(75 MHz, CDCl3): d 14.3 (C8), 19.6 (C7), 31.4, 32.5 (C6,
CH2), 75.6 (C5), 113.0, 113.9 (C11, C12), 121.8 (C3), 135.9
(C2), 144.2 (C9), 144.3 (C4), 152.4, 153.9 (C10, C13), 157.3
(C1). HRMS (ESI, IT-TOF) calculated for C64H65N8O16
+:
1201.4513; found: 1201.4517.
2.1.3. General procedure for synthesis of imines 14–19
Compound 13 (0.15 mmol) and respective aldehydes
(0.15 mmol) were solubilized in ethanol (20 mL). The mixtures
were irradiated in a Discover Cem reactor for 2 min at reflux
temperature. After finished the reactions, the products were
isolated by filtration.
Synthesis, crystal structures, and anticandidal activity of iminePlease cite this article in press as: da Silva, C.M. et al., Iminecalix[4]arenes: Microwav
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.06.013Yield: 72%. Light brown solid. Mp: 60.3–61.0 C. IR
(ATR, cm1) v: 3061, 2954, 2933, 2870, 1623, 1575, 1503,
1473, 1449, 1396, 1369, 1244, 1189, 1112, 1036, 1007, 832,
752. 1H NMR (200 MHz, CDCl3): d 0.97 (t, 3H,
J8,7 = 7.2 Hz, H8), 1.49 (sex, 2H, J7,6 = J7,8 = 7.2 Hz, H7),
1.76 (quin, 2H, J6,5 = J6,7 = 7.2 Hz, H6), 3.95 (t, 2H,
J5,6 = 7.2 Hz, H5), 6.90 (d, 2H, J2,3 = 8.5 Hz, H2), 7.22 (d,
2H, J3,2 = 8.5 Hz, H3), 7.38–7.49 (m, 3H, H12, H13), 7.87
(m, 2H, H11), 8.45 (s, 1H, H9).
13C NMR (50 MHz, CDCl3):
d 13.8 (C8), 19.2 (C7), 31.3 (C6), 67.9 (C5), 114.9 (C2), 122.1
(C3), 128.5, 128.6 (C11, C12), 130.9 (C13), 136.4 (C10), 144.6
(C4), 157.8 (C1), 158.1 (C9). HRMS (ESI, IT-TOF) calculated
for C17H20NO
+: 254.1539; found: 254.1438.
Yield: 80%. Yellow solid. Mp: 67.6–68.9 C. IR (ATR,
cm1) v: 2956, 2932, 2872, 1615, 1570, 1491, 1470, 1456,
1394, 1280, 1242, 1186, 1150, 1110, 1068, 1025, 973, 909,
837. 1H NMR (200 MHz, CDCl3): d 0.96 (t, 3H,
J8,7 = 7.2 Hz, H8), 1.47 (sex, 2H, J7,6 = J7,8 = 7.2 Hz, H7),
1.75 (quin, 2H, J6,5 = J6,7 = 7.2 Hz, H6), 3.92 (t, 2H,
J5,6 = 7.2 Hz, H5), 6.82–7.06 (m, 4H, H2, H12, H14), 7.14–
7.39 (m, 4H, H3, H13, H15), 8.52 (s, 1H, H9), 13.48 (s, 1H,
OH). 13C NMR (50 MHz, CDCl3): d 13.8 (C8), 19.1 (C7),
31.2 (C6), 67.8 (C5), 115.0 (C2), 117.0, 118.8 (C12, C14), 119.3
(C10), 122.1 (C3), 131.8, 132.4 (C13, C15), 140.9 (C4), 158.3
(C1), 160.0, 160.8 (C9, C11). HRMS (ESI, IT-TOF) calculated
for C17H20NO2
+: 270.1489; found: 270.1396.e-assisted synthesis, X-ray crystal structures, and anticandidal activity. Arabian
6 C.M. da Silva et al.Yield: 88%. Yellow solid. Mp: 75.2–76.3 C. IR (ATR,
cm1) v: 2958, 2927, 2873, 1624, 1597, 1582, 1520, 1504,
1284, 1244, 1164, 1106, 1064, 1023, 968, 804, 749, 718, 686.
1H NMR (200 MHz, CDCl3): d 0.99 (t, 3H, J8,7 = 7.2 Hz,
H8), 1.51 (sex, 2H, J7,6 = J7,8 = 7.2 Hz, H7), 1.79 (quin, 2H,
J6,5 = J6,7 = 7.2 Hz, H6), 3.99 (t, 2H, J5,6 = 7.2 Hz, H5),
6.94 (d, 2H, J2,3 = 8.0 Hz, H2), 7.29 (d, 2H, J3,2 = 8.0 Hz,
H3), 8.03 (d, 2H, J11,12 = 8.2 Hz, H11), 8.29 (d, 2H,
J12,11 = 8.2 Hz, H12), 8.56 (s, 1H, H9).
13C NMR (50 MHz,
CDCl3): d 13.8 (C8), 19.2 (C7), 31.2 (C6), 67.9 (C5), 115.0
(C2), 122.6, 123.9 (C3, C12), 129.0 (C11), 141.9, 143.2 (C4,
C10), 148.8 (C13), 154.4 (C9), 158.8 (C1). HRMS (ESI, IT-
TOF) calculated for C17H19N2O3
+: 299.1390; found: 299.1301.
Yield: 74%. Brown solid. Mp: 90.7–91.8 C. IR (ATR,
cm1) v: 2962, 2938, 2877, 1624, 1600, 1574, 1505, 1472,
1387, 1293, 1216, 1038, 1009. 1H NMR (200 MHz, CDCl3):
d 0.97 (t, 3H, J8,7 = 7.2 Hz, H8), 1.49 (sex, 2H,
J7,6 = J7,8 = 7.2 Hz, H7), 1.77 (quin, 2H,
J6,5 = J6,7 = 7.2 Hz, H6), 3.95 (t, 2H, J5,6 = 7.2 Hz, H5),
6.90 (d, 2H, J2,3 = 8.7 Hz, H2), 7.11 (t, 2H, J12,11 = J12,
F = 8.5 Hz, H12), 7.19 (d, 2H, J3,2 = 8.7 Hz, H3), 7.85 (dd,
2H, J11,12 = 8.5 Hz, J11,F = 5.7 Hz, H11), 8.40 (s, 1H, H9).
13C NMR (50 MHz, CDCl3): d 13.8 (C8), 19.2 (C7), 31.3
(C6), 67.8 (C5), 114.9 (C2), 115.7 (d, J12,F = 21.8 Hz, C12),
122.1 (C3), 130.4 (d, J11,F = 8.8 Hz, C11), 133.8 (C10), 144.3Please cite this article in press as: da Silva, C.M. et al., Iminecalix[4]arenes: Microwav
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.06.013(C4), 156.5 (C9), 157.9 (C1), 164.2 (d, J13,F = 251.1 Hz, C13).
HRMS (ESI, IT-TOF) calculated for C17H19FNO
+:
272.1445; found: 272.1351.
Yield: 69%. Light brown solid. Mp: 96.7–98.0 C. IR
(ATR, cm1) v: 2956, 2935, 2872, 1623, 1603, 1574, 1502,
1483, 1443, 1382, 1290, 1243, 1209, 1113, 1037, 928, 813,
798. 1H NMR (200 MHz, CDCl3): d 0.97 (t, 3H,
J8,7 = 7.2 Hz, H8), 1.49 (sex, 2H, J7,6 = J7,8 = 7.2 Hz, H7),
1.77 (quin, 2H, J6,5 = J6,7 = 7.2 Hz, H6), 3.95 (t, 2H,
J5,6 = 7.2 Hz, H5), 5.99 (s, 2H, OCH2O), 6.80–6.95 (m, 3H,
H2, H14), 7.11–7.27 (m, 3H, H3, H15), 7.50 (s, 1H, H11), 8.33
(s, 1H, H9).
13C NMR (50 MHz, CDCl3): d 13.8 (C8), 19.2
(C7), 31.3 (C6), 67.8 (C5), 101.4 (OCH2O), 106.6, 108.1 (C11,
C14), 114.8 (C2), 122.0 (C3), 125.2 (C15), 131.4 (C10), 144.6
(C4), 148.3, 150.1 (C12, C13), 157.2 (C9), 157.6 (C1). HRMS
(ESI, IT-TOF) calculated for C18H20NO3
+: 298.1438; found:
298.1341.
Yield: 85%. Yellow solid. Mp: 137.8–139.3 C. IR (ATR,
cm1) v: 3144, 2936, 2863, 1619, 1576, 1531, 1498, 1394,
1336, 1293, 1239, 1181, 1115, 1041, 1025, 1011, 838, 815,
739. 1H NMR (200 MHz, CDCl3): d 0.98 (t, 3H,
J8,7 = 7.2 Hz, H8), 1.50 (sex, 2H, J7,6 = J7,8 = 7.2 Hz, H7),
1.78 (quin, 2H, J6,5 = J6,7 = 7.2 Hz, H6), 3.99 (t, 2H,
J5,6 = 7.2 Hz, H5), 6.93 (d, 2H, J2,3 = 7.6 Hz, H2), 7.14 (s,
1H, H11), 7.30 (d, 2H, J3,2 = 7.6 Hz, H3), 7.41 (s, 1H, H12),e-assisted synthesis, X-ray crystal structures, and anticandidal activity. Arabian
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13C NMR (50 MHz, CDCl3): d 13.8 (C8), 19.2
(C7), 31.2 (C6), 67.9 (C5), 113.1, 113.6 (C11, C12), 115.1 (C2),
122.9 (C3), 142.4 (C4), 143.2 (C9), 152.3, 153.9 (C10, C13),
159.5 (C1). HRMS (ESI, IT-TOF) calculated for
C15H17N2O4
+: 289.1183; found: 289.1098.
2.2. Antifungal activity
2.2.1. Microorganisms
Candida albicans ATCC 18804, Candida krusei ATCC 20298,
Candida tropicalis ATCC 750, Candida parapsilosis ATCC
22019, Candida glabrata ATCC 90030 and Candida dubliniensis
CBS 7987 were procured from the American Type Culture
Collection (Manassas, VA). All strains were maintained in
the Laboratory of Mycology of the Institute of Biological
Sciences at Federal University of Minas Gerais, MG, Brazil,
on slopes of Sabouraud dextrose agar (SDA, Difco, Detroit
MI, USA) or potato dextrose agar (PDA, Difco) and sub-
cultured every two months.
2.2.2. Susceptibility assay
The antifungal susceptibility test was performed by a broth
microdilution assay according to CLSI guidelines M27-A2
(CLSI, 2002). The test compounds were dissolved in dimethyl-
sulfoxide (DMSO) and further diluted with sodium
bicarbonate-free RPMI-1640 medium (INLAB, Diadema,
SP, Brazil) buffered with 165 mM morpholine propanesulfonic
acid (MOPS, Sigma), pH 7.0, supplemented with 4 mM L-
glutamine. Each compound was tested in 10 serial concentra-
tions (2048–4.0 lg mL1). From each dilution, 100 lL was dis-
pensed into flat-bottom 96-well micro titration plates (Cral,
Cotia, SP, Brazil). Fluconazole (Sigma-Aldrich, Co, MO,
USA) was used as positive control. In addition, growth and
sterility control wells were included for each isolate tested.
Fungal species were cultured on SDA for 48 h. Concentrations
of the fungal inoculums were adjusted spectrophotometrically.
Appropriate dilutions were performed using RPMI-1640 med-
ium to obtain a two-fold test inoculum concentration (1 to
5  103 cells mL1). All assays were done in duplicate on at
least three different occasions. Inoculum suspensions and solu-
tions of test compounds were mixed (1:1) in sterile flat-bottom
96-well microplates (Difco Laboratories, Detroit, MI, USA).
Growth, sterility and toxicity control wells were included for
each isolate tested. Microplates were incubated at 35 C and
minimum inhibitory concentration (MIC) endpoints for each
microorganism were established at the end of the incubation.
MIC values for test compounds corresponded to the lowest
concentration necessary to completely inhibit (visually) fungal
growth while MIC values for fluconazole were determined as
the lowest concentration necessary to inhibit fungal growth
by 50%.
3. Results and discussion
3.1. Synthesis of compounds 6–11 and 14–19
Iminecalix[4]arenes 6–11 were prepared according to the syn-
thetic approach shown in Scheme 1. Initially, the p-tert-
butylcalix[4]arene (1) was synthesized from the condensation
reaction between p-tert-butylphenol and formaldehyde, in thePlease cite this article in press as: da Silva, C.M. et al., Iminecalix[4]arenes: Microwav
Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arabjc.2016.06.013presence of sodium hydroxide (Gutsche et al., 1990). Dealkyla-
tion of 1 with aluminum chloride and phenol led to compound
2 with 80% yield (Gutsche and Lin, 1986), which was then
treated with 1-bromobutane and sodium hydride leading to
ether 3 (Nomura et al., 2010). Nitration and subsequent reduc-
tion reactions led to intermediate 5 with a yield of 53% (from
3) (Li et al., 2009; Sansone et al., 2006). Finally, the condensa-
tion of 5 with different aromatic aldehydes, assisted by micro-
wave irradiation, resulted in iminecalix[4]arenes 6–11 in
moderate to good yields. The structural features of the deriva-
tives of the calixarenes were determined from the correspond-
ing IR, 1H NMR, 13C NMR and mass spectroscopy data.
The main absorption bands in IR spectra of compounds 6–
11 were recorded in the region of 1600 cm1, corresponding to
the stretching of C‚C and C‚N bonds, common to all the
compounds. The 1H NMR spectra showed one pair of dou-
blets for methylene bridges at d  3.25 and 4.50 ppm, that
are characteristics of cone conformation adopted by macrocy-
cles. Singlets of the imino protons (ACH‚NA) were observed
at d 7.92–8.28 ppm. For the 13C NMR spectra, the signals for
the imino carbons were observed at d  142.2–161.0 ppm.
The aldimines 14–19, corresponding to respective mono-
meric units of iminecalix[4] arenes 6–11, were synthesized in
a similar manner (Scheme 2). Treatment of 4-nitrophenol with
1-bromobutane and sodium carbonate furnished the com-
pound 12 that was reduced to give the amine 13. The conden-
sation of 13 with different aromatic aldehydes, assisted by
microwave irradiation, provides aldimines 14–19 with good
yields.
3.2. X-ray crystal structures of iminecalix[4]arenes 7 and 10
Compounds 7 and 10 have been crystallized in the monoclinic
space group P21/c with one molecule in the asymmetric unit
and therefore four ones within their unit cell. Their crystal
are very similar, including similar cell constants and volume
besides equal lattice symmetry (see crystal data in Experimen-
tal section). An illustration of the asymmetric units of com-
pounds 7 and 10 showing the labeling scheme of phenyl
rings from the calixarene basis, from one to four (C1 to C6,
C8 to C13, C15 to C20, and C22 to C27, in this order), is
shown in Figs. 1 and 2. Their crystallographically independent
molecule adopts a strongly pinched cone conformation with
two upper rim substituents pointing inwards and the other
two pointing outwards from the aromatic cavity. This uncom-
mon conformation is driven by an intramolecular p. . .p inter-
action between the phenyl rings from the upper rim
substituents attached to phenyl rings 1 and 3. These two phe-
nyl rings from either ortho-hydroxyphenyl in 7 or benzodiox-
ole in 10 are practically parallel, with a small angle between
them of 15.3(5) in 7 or 0.80(17) in 10, besides exhibiting a
staggered disposition with a separation between their centroids
of 3.912(11) A˚ in 7 or 3.525(10) A˚ in 10. These are relatively
short separations supporting the occurrence of the p. . .p inter-
action aforementioned. The occurrence of this interaction driv-
ing the pinched cone conformation has been already reported
in related iminecalix[4]arenes with four propyl groups at the
lower rim and 3-pyridyl, 2-thienyl or 2-pyrrolyl as substituents
in lieu of substituted phenyl rings in 7 and 10 (Klimentova´ and
Vojtı´sˇek, 2007) as well as in calix[4]arenes with perfluo-
rophenyl ring directly bonded to calixarene platform (Rubane-assisted synthesis, X-ray crystal structures, and anticandidal activity. Arabian
Figure 1 (a) Asymmetric unit of compound 7 drawn with 30% probability ellipsoids. (b) Top and (c) side views of compound 7 in its
crystal structure drawn as arbitrary radii sticks. In all panels, hydrogen atoms were omitted for clarity; the labeling scheme of calixarene
phenyl rings is shown, and non-covalent intramolecular contacts are shown as dashed green sticks. The two conformations of each upper
rim substituent pointing outwards from the cone are also exhibited in all panels [their site occupancy is given in (a)].
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Figure 2 (a) Asymmetric unit of compound 10 drawn with 30%
probability ellipsoids. (b) Top and (c) side views of compound 10
in its crystal structure drawn as arbitrary radii sticks. In all panels,
hydrogen atoms were omitted for clarity; the labeling scheme of
calixarene phenyl rings is shown, and the non-covalent intramolec-
ular contact is shown as dashed green sticks.
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based calix[4]arenes, p. . .p interactions are also well-known
in their recognition of guests, as occurs in benzimidazole-
functionalized calix[4]arenes used as receptors for explosive
molecules (Kandpal et al., 2013).
The two p. . .p stacked phenyl rings are not coplanar in rela-
tion to calixarene phenyl rings 1 and 3 to which they are
attached, with angles between their least-square planes of
53.2(2) and 50.8(3) in 7 or 44.55(13) and 46.43(11) in 10.
Such absence of coplanarity between the substituents and cal-
ixarene phenyl rings is also found in the two substituents
pointing outwards from the aromatic cavity. However, they
are a little less bent than those pointing inwards the cone in
10. The angles between the least-square planes of the cal-
ixarene phenyl rings 2 and 4 and their substituents were found
to be 48.1(4) (55% occupancy)/30.2(6) (45% occupancy) and
50.1(4) (60% occupancy)/39.6(7) (40% occupancy) in 7 or
23.36(11) and 27.23(13) in 10.
As can be noted from the last planarity descriptions, both
upper rim substituents attached to calixarene phenyl rings 2
and 4 of compound 7 are disordered over two sets of atomic
sites with different occupancy factors. This phenomenon is
due to the fact that both substituents can adopt two conforma-
tions changed by a rotation of approximately 180 on the
NAC single bond axis between the substituent and the cal-
ixarene fragments (Fig. 1). Additionally, in this compound,
all upper rim substituents are stabilized by the formation of
S11ð6Þ motifs wherein ortho-hydroxyl groups act as intramolec-
ular hydrogen bond donors to the imine nitrogen. The hydro-
gen bonding geometry of these motifs is shown in Table 1.
Butyl ether moieties bonded to calixarene phenyl rings 1
and 3 are present in similar syn conformations in which the
carbon chain points outwards from the cone (see
Figs. 1c and 2c). On the other hand, corresponding moieties
attached to phenyl rings 2 and 4 adopt conformations resem-
bling an anti-shaped chain with their bonded oxygen and car-
bon atoms pointing inwards and the remaining chain directed
outwards from the cone.
It is noteworthy that single crystals of the main antifungal
compound 11 (see in sequence) were obtained from dimethyl-
formamide solution as large needles (ca. 1 mm in the largest
dimension). However, they did not diffract X-rays above
1.5 A˚ resolution shell, even after using beam source from Cu
anode under high exposure time of 60 s. Therefore, we con-
cluded that these crystals did not have long-range order and
consequently their crystal structure was not solved in the dif-
ferent X-ray diffraction dataset collected. However, its mono-
clinic unit cell was determined (a= 14.79(3) A˚, b= 33.55(9)
A˚, c= 13.41(3) A˚, b= 100.68(8), V= 6581(27) A˚3, see unit
cell data for compound 11 in the Experimental section). It
was found to be similar to that of the monoclinic unit cell
found for the related compounds 7 (a= 12.405(5) A˚,
b= 30.137(12) A˚, c= 17.782(7) A˚, b= 101.502(9),
V= 6514(4) A˚3) and 10 (a= 13.713(4) A˚, b= 28.956(9) A˚,
c= 17.592(6) A˚, b= 103.184(18), V= 6801(4) A˚3). There-
fore, the determined unit cell of 11 is compatible with four
molecules thereof, which can be related by symmetry elements
of the monoclinic space group P21/c, as occurs in 7 and 10.
Thus, the unit cell data of 11 are in agreement with its expected
molecular structure, in which it adopts a pinched cone confor-
mation observed in its analogs. In order to evaluate and sug-e-assisted synthesis, X-ray crystal structures, and anticandidal activity. Arabian
Table 1 Intramolecular hydrogen bonding geometry of 7.
Phenyl ring DAH  A DAH (A˚) H  A (A˚) D  A (A˚) DAH  A ()
1 O5AH5  N1 0.82 1.90 2.626(13) 147
2 O6AH6  N2 0.82 1.82 2.56(3) 149
O60AH60  N20 0.82 1.89 2.62(4) 150
3 O7AH7  N3 0.82 1.90 2.627(13) 147
4 O8AH8  N4 0.82 1.81 2.54(3) 147
O80AH80  N40 0.82 1.91 2.65(5) 149
10 C.M. da Silva et al.gest the presence of the symmetry elements of the P21/c space
group, we have checked carefully the systematic extinctions.
There are only eight 0k0 reflections. Neither of them has vio-
lated the systematic extinction condition for the presence of the
21 screw axis symmetry element, i.e., no reflection with odd k
was observed (mean Int./r(Int.) = 0.0). This analysis suggests
the presence of a 21 screw axis parallel to the b axis, but this is
not conclusive due to the low number of 0k0 reflections. Like-
wise, 75 h0 l reflections were observed, and neither of them has
violated the systematic extinction condition for occurrence of a
c-glide perpendicular to the b axis, i.e., no h0 l reflection with
odd l was detected (mean Int./r(Int.) = 0.0). Therefore, the
presence of c-glide symmetry element can be stated more surely
in this structure. In this way, compound 11 can be arranged
in the solid phase with the P21/c space group symmetry
elements.
3.3. Antifungal activity
As shown in Table 2, wherein the MIC values obtained for
each compound are presented, inhibition of all six tested Can-
dida strains by iminecalix[4]arenes 6–11 was higher than their
respective monomers. This indicates a general increase in anti-
fungal potency of the aldimine monomers upon their cycliza-
tion into calixarene platform. Such a conclusion does open a
newer perspective of enhancing the antifungal profile of well-
known fungicidal compounds through their cyclization or even
anchoring them on calixarene grounds. The ratio between the
minimal inhibitory concentration (MIC) of a monomer and
the corresponding iminecalix[4]arene ranged from 2.05 (MIC
ratio between compounds 16 and 8 against C. parapsilosis)
to 36.50 (MIC ratio between compounds 19 and 11 against
C. albicans, C. tropicalis and C. parapsilosis). Compound 11
was the most active among all compounds tested in this study.
It exhibited low MIC values comparable to that of positive
control (fluconazole), which is a potent inhibitor of fungal
growth. The MIC values for compound 11 ranged from 0.05Table 2 Minimal inhibitory concentration (MIC; mmol L1) of co
Fungal strains Compounds
6 7 8 9 10 11
C. albicans 0.48 0.45 0.41 0.45 0.41 0.05
C. krusei 0.48 0.23 0.21 0.23 0.21 0.05
C. tropicalis 0.48 0.45 0.41 0.45 0.41 0.05
C. parapsilosis 0.24 0.11 0.21 0.23 0.41 0.05
C. glabrata 0.48 0.23 0.21 0.45 0.41 0.11
C. dubliniensis 0.24 0.45 0.21 0.23 0.41 0.05
a Flu stands for fluconazole (positive control).
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MIC values of fluconazole ranged from 0.0008 to
0.10 mmoL1. Compound 11 (MIC of 0.05 mmoL1) was even
twice more active than fluconazole (MIC of 0.10 mmoL1)
against C. krusei.
Inspection of MIC values into either cyclic or monomeric
sets of aldimines studied here allowed us to establish some
structure-activity relationships. The antifungal potency of the
iminecalix[4]arenes with nitro group (8) or fluorine (9) at 4-
position of the substituent phenyl ring has been almost the
same against all Candida species except against C. glabrata.
This activity is either 0.21–0.23 mmol L1 or 0.41–
0.45 mmol L1. The decoration of the substituent phenyl ring
improves a few of the activities of the iminecalix[4]arenes, since
compound 6 presented without any decoration in its sub-
stituent phenyl moiety exhibited the highest MIC value
(0.48 mmol L1) among all iminecalix[4]arenes against four
Candida species. The highest increase in this biological prop-
erty through the decoration of this phenyl ring occurred in
compound 7 present with 2-hydroxyl group (MIC of
0.11 mmol L1 against C. parapsilosis). However, decoration
of phenyl ring with 3,4-methylenedioxy does not change the
antifungal property of the iminecalix[4]arene 10 (MIC of
0.41 mmol L1 against five Candida species). Among the
monomers, this trend is not observed. Fluoro derivative 17
has presented the same high MIC of 3.77 mmol L1 against
all Candida species. Undecorated aldimine 14 had the highest
MIC of 4.04 mmol L1 against two species, but the com-
pounds 15, 16 and 18 also showed higher MIC values of
3.80, 3.43 and 3.44 mmol L1, respectively. The only similarity
with iminecalix[4]arenes is the conservation of the lowest MIC
values within the set of the monomers for the nitrofuran
derivative 19, which has showed against C. krusei a MIC value
of 0.22 mmol L1 comparable to that of the calixarene-based
compounds. This states that nitrofuran group attached to phe-
nyl moiety increases the antifungal activity of the aldimine and
its cyclic analog.mpounds 6–11 and 14–19 against fungal strains.
14 15 16 17 18 19 Flua
2.02 1.90 1.72 3.77 3.44 1.78 0.0008
1.01 1.90 0.86 3.77 1.72 0.22 0.10
4.04 3.80 3.43 3.77 3.44 1.78 0.0008
1.01 0.48 0.43 3.77 1.72 1.78 0.007
4.04 0.95 3.43 3.77 3.44 1.78 0.03
2.02 1.90 1.72 3.77 1.72 0.89 0.0008
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Six iminecalix[4]arenes and their corresponding monomeric units have
been synthesized in this study with moderate to good yields. Their
structural backbones were confirmed using IR, 1H NMR, 13C NMR
and mass spectroscopy data. In addition, crystal structures of two imi-
necalix[4]arenes provided interesting conformation knowledge thereof.
Both compounds have assumed pinched cone conformation kept
stable by means of weak intramolecular p. . .p interaction between phe-
nyl rings from upper rim substituents pointing inwards the calixarene
cavity. These substituents and those pointing outwards from the cone
are twisted relative to calixarene phenyl rings in which they are
bonded.
From the antifungal profile, it was possible to conclude that
calixarene-based aldimines are more active against Candida strains
than their monomers. Such an increase in the antifungal property of
iminecalix[4]arenes has achieved up to 35.60 times higher activity than
the corresponding monomeric molecule. Such a conclusion does open
a new perspective of enhancing the antifungal profile of well-known
fungicidal compounds through their cyclization or even anchoring
them in calixarene grounds. Lastly, the antifungal response of the imi-
necalix[4]arene with nitrofuran moiety was comparable to that of flu-
conazole. Our target compound was twice more active than
fluconazole against C. krusei. This finding highlights the fact that such
iminecalix[4]arenes can act as promising antifungal agents. Addition-
ally, it can also guide the search for more powerful antifungal analogs
supported on calixarene platform.
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